Table 8 Methodological quality assessment of published randomized controlled trials using the Cochrane risk of bias tool (2nd version)
From: Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
Study | Bias from the randomization process | Bias caused by deviations from intended interventions | Bias caused by missing outcome data | Bias in measurement of the outcome | Bias in selection of the reported results | Overall risk of bias |
|---|---|---|---|---|---|---|
Dyek [2023] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
Tahami Monfared 2023] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
Salloway [2021] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |
Bateman [2018] | Low risk | Low risk | Low risk | Low risk | Low risk | Low risk |